Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Talphera Inc | TLPH | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.9459 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 0.72 - 1.61 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 0.9459 | USD |
Talphera Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
16.12M | 16.97M | - | 651k | -18.4M | -1.08 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Talphera News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TLPH Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.02 | 1.0495 | 0.92 | 0.97806 | 44,295 | -0.0741 | -7.26% |
1 Month | 1.15 | 1.24 | 0.92 | 1.08 | 71,743 | -0.2041 | -17.75% |
3 Months | 1.09 | 1.61 | 0.84 | 1.16 | 99,701 | -0.1441 | -13.22% |
6 Months | 0.86 | 1.61 | 0.72 | 1.11 | 117,553 | 0.0859 | 9.99% |
1 Year | 0.86 | 1.61 | 0.72 | 1.11 | 117,553 | 0.0859 | 9.99% |
3 Years | 0.86 | 1.61 | 0.72 | 1.11 | 117,553 | 0.0859 | 9.99% |
5 Years | 0.86 | 1.61 | 0.72 | 1.11 | 117,553 | 0.0859 | 9.99% |
Talphera Description
AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain. The company's products under pipeline are ARX-02 and ARX-03. The majority of its revenue is generated from DSUVIA product sales in the United States. |